Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Cash from Investing Activities (2018 - 2025)

AdaptHealth (AHCO) has 8 years of Cash from Investing Activities data on record, last reported at -$124.5 million in Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 43.28% year-over-year to -$124.5 million; the TTM value through Dec 2025 reached -$303.2 million, up 2.28%, while the annual FY2025 figure was -$303.2 million, 2.28% up from the prior year.
  • Cash from Investing Activities reached -$124.5 million in Q4 2025 per AHCO's latest filing, down from -$92.7 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $9.6 million in Q2 2025 and bottomed at -$1.2 billion in Q1 2021.
  • Average Cash from Investing Activities over 5 years is -$160.3 million, with a median of -$91.6 million recorded in 2023.
  • Peak YoY movement for Cash from Investing Activities: crashed 2536.4% in 2021, then soared 111.82% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$266.2 million in 2021, then surged by 45.24% to -$145.8 million in 2022, then soared by 37.98% to -$90.4 million in 2023, then increased by 3.92% to -$86.9 million in 2024, then crashed by 43.28% to -$124.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$124.5 million in Q4 2025, -$92.7 million in Q3 2025, and $9.6 million in Q2 2025.